1-3 of 3
Haijun Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Therapeutic Combining CS055 with Chiglitazar Targets Leukemia Stem and Progenitor Cells in Acute Myeloid Leukemia

Hui Zhou, Dongmei Qin, Chendi Xie, Jie Zhou, Wenjuan Li, Mengya Zhong, Yuelong Jiang, Manman Deng, Haijun Zhao, Yong Zhou, Qian Lai, Zhihong Fang, Yiming Luo, Bing Xu, Jie Zha
Journal: Blood
Blood (2022) 140 (Supplement 1): 11731.
https://doi.org/10.1182/blood-2022-166807
Published: 2022
Journal Articles

Low-Dose Triptolide Enhances Bromodomain Inhibitor JQ1-Induced Apoptosis of Acute Myeloid Leukemia Cells Via Down-Regulation of c-Myc Following RAS/MEK/ERK Inhibition

Bing Xu, Yuanfei Shi, Haijun Zhao, Yi Qiu, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5757.
https://doi.org/10.1182/blood-2019-123740
Published: 2019
Journal Articles

Simultaneous Inhibition of Mcl-1 and Induction of DNA Damage Accumulation By Chidamide, a Novel Selective HDACi, Potentiates the Cytotoxicity of ABT-199 in Acute Myeloid Leukemia

Bing Xu, Kai Chen, Qianying Yang, Jie Zha, Haijun Zhao, Liying Feng, Xiaolei Chen, Guo Fu, Ken H. Young, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5767.
https://doi.org/10.1182/blood-2019-121721
Published: 2019